Fake weight-loss pens and UK law
Counterfeit GLP-1 weight-loss pens are not just a safety issue — they sit at the intersection of medicines regulation, fraud law, advertising rules, and consumer protection. This page summarises the UK legal framing for a non-specialist.
What “counterfeit” covers
For UK regulators, “counterfeit medicine” includes a range of problems: a product passing itself off as a licensed medicine; a licensed medicine that has been tampered with or relabelled; a medicine with no, less, or more active ingredient than declared; or a product containing a different active ingredient entirely. The MHRA also uses the term “falsified medicines”.
Which UK laws are in play
- Human Medicines Regulations 2012 — the core UK framework for licensing, supply, and advertising of medicines.
- Falsified Medicines rules — UK provisions on falsified medicines, including verification and reporting.
- Consumer Protection from Unfair Trading Regulations — misleading commercial practices.
- Trade marks and intellectual property law — counterfeit branded pens infringe registered trade marks of the original manufacturers.
- Fraud Act 2006 — applies where consumers are deceived.
MHRA's role
The MHRA is the UK regulator for medicines and medical devices. It investigates suspected counterfeit and falsified medicines, runs the Yellow Card scheme for reports, issues Drug Safety Updates, and can prosecute. Reports from consumers and clinicians are an important part of how counterfeit supply chains are detected.
Advertising rules
Prescription-only medicines may not be advertised to the public in the UK. Counterfeit pens are sometimes advertised under generic terminology (“weight-loss pens”), via influencer content, or in closed messaging groups. Each of these can engage advertising-rules enforcement as well as medicines law.
What consumers should do
- If you have a suspect pen, stop using it.
- Seek medical advice (NHS 111 or 999 if urgent).
- Do not discard the product or packaging — they may be needed by the MHRA.
- Report to the MHRA via Yellow Card and the MHRA's counterfeit reporting route.
- Report to Action Fraud if you have been scammed.
Red-flag claims
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“Genuine pens from an EU pharmacy — fully legal UK”
EU-origin product still needs lawful UK import and supply. Many such offers are not in fact genuine EU pharmacy product.
“Just for personal use, all paperwork handled”
'Paperwork handled' is sometimes a euphemism for 'we are routing around UK supply rules'. Be wary.
“Discounted Mounjaro — clinic surplus”
Surplus prescription medicine being resold outside the regulated supply chain is unlawful supply.
“If anything goes wrong, just blame the doctor”
Suggests the seller knows the supply is outside the regulated framework. Avoid.
Sources & further reading
- MHRA — Medicines and Healthcare products Regulatory Agency — gov.uk
- MHRA Yellow Card — yellowcard.mhra.gov.uk
- Report a problem with a medicine or medical device (MHRA) — gov.uk
- MHRA Drug Safety Update (publication landing) — gov.uk
Filter by therapeutic area for the specific GLP-1 / counterfeit pen alert.
- Action Fraud (UK) — actionfraud.police.uk
- Human Medicines Regulations 2012 — legislation.gov.uk
Frequently asked questions
- Is selling a fake Ozempic pen illegal in the UK?
- Yes, in multiple ways. Selling or supplying a falsified medicine is an offence under UK medicines regulation. Counterfeit pens often also engage fraud, trademark, and consumer-protection law. The MHRA leads UK enforcement on counterfeit medicines.
- What does the MHRA actually do about counterfeit pens?
- The MHRA enforces medicines law in the UK, investigates suspected counterfeit and falsified medicines, issues Drug Safety Updates, and prosecutes serious cases. It also works with international agencies on supply-chain interdiction.
- Is it illegal to buy a fake pen, even if I didn't know?
- Possession by a consumer who has been deceived is typically treated very differently from supply, but the more important question is the safety risk. Stop using the product, seek medical advice, and report to the MHRA. Consult a qualified solicitor if you face legal exposure.
- What about advertising fake pens on social media?
- UK advertising rules prohibit advertising unauthorised medicines and prescription-only medicines to the public. Adverts for unbranded 'weight-loss pens', or branded counterfeit product, can engage MHRA, ASA, and platform-level enforcement.
- Can the MHRA take action against overseas sellers?
- MHRA action against overseas sellers is harder, but UK consumer-protection, customs, and international cooperation routes do exist. Reporting suspected counterfeits via Yellow Card helps the picture even when prosecution is not realistic.